Wisconsin Evaluation of Emergency Department Care Coordination

January 8, 2025 updated by: University of Wisconsin, Madison

Evaluation of an Intensive Care Coordination Program to Reduce Use of Hospital Emergency Department Services by Wisconsin Medicaid Members

The State of Wisconsin is now expanding its investment in care coordination models as an effort to reduce inappropriate hospital emergency department (ED) use, improve health outcomes, and reduce Medicaid expenditures. This effort begins with a pilot program to support emergency department care coordination in hospitals and health systems that apply and are selected to participate in the pilot program.

The Wisconsin Medicaid program seeks to understand whether this program achieves its intended goals and, specifically, whether the Medicaid payment for such care coordination services produces the intended program outcomes. Hospitals will select members that will receive care coordination services. In a quasi-experimental approach, the study team will compare members that do vs. do not receive the services will be used examine the effects of care coordination and referrals on total ED visits, primary-care treatable ED visits, non-emergent ED visits, and health care costs, as well as the specific effects of referring patients to providers who offer low-cost and after-hours care. To assess the importance of targeting, study team will conduct stratified analyses of vulnerable groups such as people with disabilities and individuals with specific clinical needs.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
3405

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • United States
    • Wisconsin
      • Appleton, Wisconsin, United States, 54911
        • ThedaCare
      • Glendale, Wisconsin, United States, 53217
        • Ascension Wisconsin
      • Milwaukee, Wisconsin, United States, 53202
        • Aurora Health Care
      • Wauwatosa, Wisconsin, United States, 53226
        • Froedtert Health , Wisconsin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 64 years (Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Inclusion Criteria:

  • Adults who are Medicaid enrolled
  • Have had 5+ emergency department visits in the past year

Exclusion Criteria:

  • Participants who are concurrently eligible for Medicare
  • Children (individuals age <18 years).

Description

Inclusion Criteria:

  • Adults who are Medicaid enrolled
  • Have had 5+ emergency department visits in the past year

Exclusion Criteria:

  • Participants who are concurrently eligible for Medicare
  • Children (individuals age <18 years).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Intensive Care Coordination
Intensive Care Coordination along with Standard of Care
Other: Intensive Care Coordination

Intensive care coordination will include:

  • Discharge instructions and contacts for following up on care and treatment
  • Referral information
  • Appointment scheduling
  • Medication instructions
  • Intensive care coordination by a social worker, case manager, nurse, or care coordinator to connect Medical Assistance (MA) recipient to a primary care provider or to a managed care organization
  • Information about other health and social resources, such as transportation and housing
  • Sharing of information (discharge instructions, medication information, and care plan information) with managed care organization in which patients are enrolled, if applicable
Control
Standard of Care alone

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Time Frame
Total Number of Emergency Department Visits
Time Frame: 6 months
6 months
Total Number of Emergency Department Visits
Time Frame: 12 months
12 months
Total Number of Emergency Department Visits
Time Frame: 18 months
18 months
Total Number of Emergency Department Visits
Time Frame: 24 months
24 months
Total Number of Emergency Department Visits for Primary Care Preventable and/or Non-Emergent Conditions
Time Frame: 6 months
6 months
Total Number of Emergency Department Visits for Primary Care Preventable and/or Non-Emergent Conditions
Time Frame: 12 months
12 months
Total Number of Emergency Department Visits for Primary Care Preventable and/or Non-Emergent Conditions
Time Frame: 18 months
18 months
Total Number of Emergency Department Visits for Primary Care Preventable and/or Non-Emergent Conditions
Time Frame: 24 months
24 months
Cost to Medicaid for all Emergency Department Visits
Time Frame: 6 months
6 months
Cost to Medicaid for all Emergency Department Visits
Time Frame: 12 months
12 months
Cost to Medicaid for all Emergency Department Visits
Time Frame: 18 months
18 months
Cost to Medicaid for all Emergency Department Visits
Time Frame: 24 months
24 months
Cost to Medicaid for Emergency Department Use for Primary Care Preventable and/or Non-Emergent Conditions
Time Frame: 6 months
6 months
Cost to Medicaid for Emergency Department Use for Primary Care Preventable and/or Non-Emergent Conditions
Time Frame: 12 months
12 months
Cost to Medicaid for Emergency Department Use for Primary Care Preventable and/or Non-Emergent Conditions
Time Frame: 18 months
18 months
Cost to Medicaid for Emergency Department Use for Primary Care Preventable and/or Non-Emergent Conditions
Time Frame: 24 months
24 months

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Total Number of Primary Care Visits
Time Frame: 6, 12, 18, and 24 months
6, 12, 18, and 24 months
Number of Participants Who Used Any Primary Care Visits
Time Frame: 6, 12, 18, and 24 months
6, 12, 18, and 24 months
Number of Participants Who Used Specialty Care Visits
Time Frame: 6, 12, 18, and 24 months
6, 12, 18, and 24 months
Total Number of Specialty Care Visits
Time Frame: 6, 12, 18, and 24 months
6, 12, 18, and 24 months
Number of Participants with Any Hospitalizations
Time Frame: 6, 12, 18, and 24 months
6, 12, 18, and 24 months
Number of Hospitalization Events
Time Frame: 6, 12, 18, and 24 months
6, 12, 18, and 24 months
Number of visits to use behavioral health resources, if applicable for the participant
Time Frame: 6, 12, 18, and 24 months
6, 12, 18, and 24 months
Number of visits to use alcohol and other drug abuse resources if applicable for the participant
Time Frame: 6, 12, 18, and 24 months
6, 12, 18, and 24 months
Total Cost Related to the Use of Behavioral Health Resources if applicable for the participant
Time Frame: 6, 12, 18, and 24 months
6, 12, 18, and 24 months
Total Cost Related to Use of Alcohol and other Drug Abuse Resources if applicable for the participant
Time Frame: 6, 12, 18, and 24 months
6, 12, 18, and 24 months
Total costs of care to Medicaid
Time Frame: 6, 12, 18, and 24 months
6, 12, 18, and 24 months
Number of participants enrolled in Temporary Assistance for Needy Families (TANF)
Time Frame: 6, 12, 18, and 24 months
6, 12, 18, and 24 months
Number of participants enrolled in FoodShare
Time Frame: 6, 12, 18, and 24 months
FoodShare is a program that helps people with limited resources buy the food they need for good health.
6, 12, 18, and 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Wisconsin, Madison

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Rebecca Myerson, MPH, PhD, University of Wisconsin, Madison

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
March 1, 2022

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 15, 2024

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 15, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
September 9, 2020

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 14, 2020

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
September 16, 2020

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 25, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 8, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2020-1211
  • A538500 (Other Identifier: UW- Madison)
  • SMPH/POP HEALTH SCI/POP HEALTH (Other Identifier: UW Madison)
  • MSN240705 (Other Grant/Funding Number: DHHS, CENTERS FOR MEDICARE & MEDICAID SE)
  • Protocol Version April 2020 (Other Identifier: UW Madison)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergency Department Visit

Clinical Trials on Intensive Care Coordination

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings